These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17630928)

  • 1. Targetability of human disease genes.
    Sakharkar MK; Sakharkar KR
    Curr Drug Discov Technol; 2007 Jun; 4(1):48-58. PubMed ID: 17630928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Druggability of human disease genes.
    Sakharkar MK; Sakharkar KR; Pervaiz S
    Int J Biochem Cell Biol; 2007; 39(6):1156-64. PubMed ID: 17446117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease gene discovery through integrative genomics.
    Giallourakis C; Henson C; Reich M; Xie X; Mootha VK
    Annu Rev Genomics Hum Genet; 2005; 6():381-406. PubMed ID: 16124867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A machine learning approach for genome-wide prediction of morbid and druggable human genes based on systems-level data.
    Costa PR; Acencio ML; Lemke N
    BMC Genomics; 2010 Dec; 11 Suppl 5(Suppl 5):S9. PubMed ID: 21210975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospects of medicinal use of achievements in genomics: the beginning of era of complete genome medical genetics].
    Sverdlov ED
    Patol Fiziol Eksp Ter; 2001; (1):3-22. PubMed ID: 11247299
    [No Abstract]   [Full Text] [Related]  

  • 6. Using bioinformatics for drug target identification from the genome.
    Jiang Z; Zhou Y
    Am J Pharmacogenomics; 2005; 5(6):387-96. PubMed ID: 16336003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative genomics for detecting human disease genes.
    Moreno C; Lazar J; Jacob HJ; Kwitek AE
    Adv Genet; 2008; 60():655-97. PubMed ID: 18358336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocomputational strategies for microbial drug target identification.
    Sakharkar KR; Sakharkar MK; Chow VT
    Methods Mol Med; 2008; 142():1-9. PubMed ID: 18437301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide identification of genes likely to be involved in human genetic disease.
    López-Bigas N; Ouzounis CA
    Nucleic Acids Res; 2004; 32(10):3108-14. PubMed ID: 15181176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Database tools in genetic diseases research.
    Bianco AM; Marcuzzi A; Zanin V; Girardelli M; Vuch J; Crovella S
    Genomics; 2013 Feb; 101(2):75-85. PubMed ID: 23147677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss-of-function genetic diseases and the concept of pharmaceutical targets.
    Ségalat L
    Orphanet J Rare Dis; 2007; 2():30. PubMed ID: 17674486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic dissection of diseases: design and methods.
    Hoh J; Ott J
    Curr Opin Genet Dev; 2004 Jun; 14(3):229-32. PubMed ID: 15172663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative genomics and drug development.
    Lum PY; Derry JM; Schadt EE
    Pharmacogenomics; 2009 Feb; 10(2):203-12. PubMed ID: 19207021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolutionary survey of druggable protein targets with respect to their subcellular localizations.
    Wang X; Wang R; Zhang Y; Zhang H
    Genome Biol Evol; 2013; 5(7):1291-7. PubMed ID: 23749117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical genomics and medicinal systems biology: chemical control of genomic networks in human systems biology for innovative medicine.
    Kim TK
    J Biochem Mol Biol; 2004 Jan; 37(1):53-8. PubMed ID: 14761303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of using SNPs in the understanding and treatment of disease.
    Schifreen RS; Storts DR; Buller AM
    Biotechniques; 2002 Jun; Suppl():14-6, 18, 20-1. PubMed ID: 12083392
    [No Abstract]   [Full Text] [Related]  

  • 17. Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics.
    Cooper DN; Chen JM; Ball EV; Howells K; Mort M; Phillips AD; Chuzhanova N; Krawczak M; Kehrer-Sawatzki H; Stenson PD
    Hum Mutat; 2010 Jun; 31(6):631-55. PubMed ID: 20506564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How next-generation sequencing is transforming complex disease genetics.
    Kilpinen H; Barrett JC
    Trends Genet; 2013 Jan; 29(1):23-30. PubMed ID: 23103023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms underlying structural variant formation in genomic disorders.
    Carvalho CM; Lupski JR
    Nat Rev Genet; 2016 Apr; 17(4):224-38. PubMed ID: 26924765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-basic estimates the size of druggable human genome.
    Plewczynski D; Rychlewski L
    J Mol Model; 2009 Jun; 15(6):695-9. PubMed ID: 18663489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.